Pregnant Women Could Be Prescribed Statins To Lower Chance Of

Pregnant Women Could Be Prescribed Statins To Lower Chance Of When cholesterol builds up, it lines the walls of the arteries, which increases risk of heart disease and stroke. most women do well on statins, and the medication does lower their incidence of cardiovascular disease. in fact, statins reduce heart attack and stroke risk by about 20%. one study found that statin therapy reduced cardiovascular. The majority of our patients who take statin medications to lower their cholesterol are age 50 and older. however, some younger women can also benefit from taking statins – particularly those with familial hypercholesterolemia (fh), a genetic condition that causes extremely high cholesterol, despite the patient's best efforts with diet and exercise.

Statin Safety In Pregnancy The Pulse Over an average 13.5 years of follow up, women with better cardiovascular health measures after giving birth (scores higher than 76) had a 57% lower risk of developing cardiovascular disease than women with poorer cardiovascular health measures (those who scored below 67). The fda now states that “statins are safe to use if you are not pregnant but can become pregnant,” signaling another potential change in the approach to statin use in women. the practical implications of this latest announcement by the fda are not straightforward and create ambiguity in the already nuanced territory of cholesterol. Available evidence from those women exposed to statins in early pregnancy shows no increased risk of fetal abnormalities, and women with exposure can be reassured that careful and standard pre natal screening for congenital abnormalities can determine the safety and or desirability of carrying a pregnancy to term. statins remain contraindicated. Among all the analyzed studies, 46,675 (27%) of the 174,149 patients were females. across all the trials, statin therapy (or higher intensity statin therapy) decreased tc and ldl c and compared with the control (or lower intensity statin) from baseline to one year, in both men and women, by similar values.